Syllabus · Historical · V4 (2023) · Musculoskeletal System

L2 · Musculoskeletal System Pharmacology

L2.i · Musculoskeletal System Pharmacology

Official V4 objective
Understand the pharmacology of neuromuscular blocking drugs and reversal agents.
8 SAQ topics 14 SAQ appearances 14 VIVA stations

Written examination

SAQ history

14 appearances
In relation to neuromuscular blocking drugs – Discuss the factors that influence the speed of ONSET of neuromuscular block.
38%
Discuss the factors that may potentially influence the speed of onset of neuromuscular blockade.
16%
Describe the factors that influence the speed of ONSET of neuromuscular blockade.
0%
Outline the mechanisms that potentiate the action of non-depolarising muscle relaxants and give examples.
15%
Outline three (3) factors that alter the pharmacodynamic response of non-depolarising neuro-muscular blocking drugs and describe the mechanism by which they may occur.
Rocuronium vs. Cisatracurium
1 exam appearance
Compare and contrast rocuronium and cisatracurium.
32%
Suxamethonium — Clinical Use
2 exam appearances
Outline the advantages (15% of marks) and disadvantages (85% of marks) of the clinical use of suxamethonium.
46%
Suxamethonium is a non-competitive partial agonist. Explain what is meant by this statement using definitions of the underlined terms (50% of marks). List the advantages and disadvantages of suxamethonium within Intensive Care practice (50% of marks).
59.1%
Suxamethonium — Pharmacology
3 exam appearances
Describe the pharmacology of suxamethonium.
63%
Describe the pharmacology of suxamethonium.
Describe the pharmacology of suxamethonium
58%
Suxamethonium vs. Rocuronium
1 exam appearance
Compare and contrast the pharmacology of suxamethonium and rocuronium.
75%
Vecuronium
2 exam appearances
Describe factors that prolong the action of neuromuscular blocking agents (60% of Marks) Outline the pharmacokinetics and pharmacodynamics of vecuronium (40% of Marks).
20%
Describe the pharmacology of vecuronium, including factors that prolong its action of neuromuscular blockade.
13%

Oral examination

VIVA history

14 stations

Sources: objective text from the relevant CICM syllabus; historical SAQ and VIVA wording from CICM examiner reports.